Intercept Pharmaceuticals, Inc. (ICPT): Price and Financial Metrics

Intercept Pharmaceuticals, Inc. (ICPT)

Today's Latest Price: $110.48 USD

9.30 (-7.76%)

Updated Dec 6 10:12am

Add ICPT to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 326 in Biotech

See all "A" rated Strong Buy stocks

ICPT Stock Summary

  • ICPT's price/sales ratio is 11.36; that's higher than the P/S ratio of 90.66% of US stocks.
  • ICPT's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of 93.23% of US stocks.
  • Revenue growth over the past 12 months for Intercept Pharmaceuticals Inc comes in at 38%, a number that bests 86.38% of the US stocks we're tracking.
  • If you're looking for stocks that are quantitatively similar to Intercept Pharmaceuticals Inc, a group of peers worth examining would be CERS, NSTG, PLUG, PACB, and VUZI.
  • ICPT's SEC filings can be seen here. And to visit Intercept Pharmaceuticals Inc's official web site, go to
ICPT Daily Price Range
ICPT 52-Week Price Range

ICPT Stock Price Chart More Charts

ICPT Price/Volume Stats

Current price $110.48
Prev. close $119.78
Day low $107.36
Day high $120.57
50-day MA $79.11
200-day MA $82.11
52-week high $131.87
52-week low $56.76
Volume 516,187
Avg. volume 739,915
Dividend yield N/A
Market Cap 3.62B

Intercept Pharmaceuticals, Inc. (ICPT) Company Bio

Intercept Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat chronic underserved liver diseases. The company was founded in 2002 and is based in New York, New York.

ICPT Latest News Stream

Event/Time News Detail
Loading, please wait...

ICPT Latest Social Stream

Loading social stream, please wait...

View Full ICPT Social Stream

ICPT Price Returns

1-mo 39.55%
3-mo 76.09%
6-mo 38.95%
1-year 3.44%
3-year 4.38%
5-year -23.09%
YTD 9.61%
2018 72.53%
2017 -46.23%
2016 -27.25%
2015 -4.26%
2014 128.47%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 1.0759 seconds.